Background. Atrial fibrillation is common in advanced heart failure, but its prognostic significance is controversial.
Methods and Results. We evaluated the relation of atrial rhythm to overall survival and sudden death in 390 consecutive advanced heart failure patients. Etiology of heart failure was coronary artery disease in 177 patients (45%) and nonischemic cardiomyopathy or valvular heart disease in 213 patients (55%). Mean left ventricular ejection fraction was 0.19±0.07. Seventy-five patients (19%o) had paroxysmal (26 patients) or chronic (49 patients) atrial fibrillation. Compared with patients with sinus rhythm, patients with atrial fibrillation did not differ in etiology of heart failure, mean pulmonary capillary wedge pressure on therapy, or embolic events but were more likely to be receiving warfarin and antiarrhythmic drugs and had a slightly higher left ventricular ejection fraction. After a mean follow-up of 236±303 days, 98 patients died: 56 (57%) died suddenly, and 36 (37%) died of progressive heart failure. Actuarial 1-year overall survival was 68%, and sudden death-free survival was 79%. Actuarial survival was significantly worse for atrial fibrillation than for sinus rhythm patients (52% versus 71%, p =0.0013). Similarly, sudden death-free survival was significantly worse for atrial fibrillation than for sinus rhythm patients (69% versus 82%, p=0.0013). By Cox proportional hazards model, pulmonary capillary wedge pressure on therapy, left ventricular ejection fraction, coronary artery disease, and atrial fibrillation were independent risk factors for total mortality and sudden death. For patients who had pulmonary capillary wedge pressure of less than 16 mm Hg on therapy, atrial fibrillation was associated with poorer 1-year survival (44% versus 83%, p=0.00001); however, in the high pulmonary capillary wedge pressure group, atrial fibrillation did not confer an increased risk (58% versus 57%).
Conclusions. Atrial fibrillation is a marker for increased risk of death, especially in heart failure patients who have lower filling pressures on vasodilator and diuretic therapy. Whether aggressive attempts to maintain sinus rhythm will reduce this risk is unknown. (Circulation 1991; 84:40-48) A trial fibrillation is common in advanced heart failure, but its relation to mortality is controversial.1-10 In previous, smaller studies of heart failure patients, the effects of atrial fibrillation on survival have been variably reported as adverse,1,2 insignificant,3-9 and even beneficial.10 To clarify the prognostic significance of atrial fibrillation in advanced heart failure, we evaluated the relation of the atrial rhythm to survival and sudden death in 390 consecutive patients with advanced heart failure.
Methods

Patients
The study population comprised 390 consecutive patients with advanced heart failure of New York Heart Association functional class III or IV on admission who were hospitalized for optimization of medical therapy, often in conjunction with evaluation for heart transplantation, during the period of April 1983 through April 1990. Patients were admitted to the UCLA Medical Center Coronary Care Unit, where they underwent placement of a pulmonary artery catheter to guide intravenous followed by oral vasodilator and diuretic therapy to achieve specific hemodynamic goals.1112 Only patients who achieved hemodynamic improvement enabling hospital discharge are included in the present analysis. Hemodynamic, echocardiographic, and clinical data were collected prospectively for each patient, recorded on a standard data form, and entered into a computerized data base. The cardiac rhythm at discharge and history of atrial fibrillation were determined by retrospective review of electrocardiograms and hospital charts.
In general, it is our approach to attempt to restore sinus rhythm before hospital discharge in patients who have been anticoagulated if atrial fibrillation is of recent onset (less than 3-6 months). However, this was left to the discretion of the attending physician. We also routinely recommend anticoagulation with warfarin in the absence of contraindications to patients with 1) history of prior thromboembolic event, 2) chronic or paroxysmal atrial fibrillation, or 3) pedunculated or irregular-appearing left ventricular thrombus on echocardiography or contrast ventriculography.
Follow-up
Patients were followed by one of the investigators in the UCLA Cardiomyopathy Clinic. In the event of death, information regarding the circumstances at the time of death was obtained through the family, personal physician, and autopsy, when available. Telephone contact with all patients, their families, and/or physicians was attempted in April and May 1990. Fifteen patients (3.8%) were lost to follow-up (sinus rhythm, 4.1%; atrial fibrillation, 2.7%;p=0.4). Definitions For our study, "sudden death" was defined as unexpected death within 15 minutes of a change in symptoms or during sleep, "arrhythmic death preceded by increasing symptoms" was unexpected death occurring more than 15 minutes after but within 24 hours of a change in symptoms, "atrial fibrillation" was irregular undulation of the baseline generally associated with an irregular ventricular rhythm (a distinction from atrial flutter was not made), "paroxysmal atrial fibrillation" was when a patient had a history of atrial fibrillation but was in sinus rhythm at hospital discharge, and "chronic atrial fibrillation" was when a patient had persistent atrial fibrillation at hospital discharge.
Statistics
For discrete variables, x2 tests were used. For continuous variables, independent t tests were used. Oneyear actuarial survival curves and Cox proportional hazards models were constructed using BMDP programs (BMDP Statistical Software, University of California Press, 1985) . The variables analyzed in the univariate Cox proportional hazards model were final pulmonary capillary wedge pressure, pulmonary artery systolic pressure, cardiac index, left ventricular ejection fraction, presence of coronary artery disease, atrial fibrillation, final serum sodium, antiarrhythmic drug therapy at hospital discharge, warfarin at hospital discharge, previous embolic event, and acceptance or rejection for heart transplantation. Hemodynamic variables and ejection fraction were used as continuous variables.
Variables identified as significant (p<0.1) univariate predictors were then evaluated in the multivariate analysis. To assess the interaction between pulmonary capillary wedge pressure and atrial fibrillation in the multivariate Cox proportional hazards model, an "interaction variable" (the product of pulmonary capillary wedge pressure and atrial fibrillation) was evaluated in the multivariate model (see below). Sudden death-free survival curves were constructed by censuring all nonsudden deaths from the analysis at the time of death. Patients undergoing heart transplantation were withdrawn from analysis at the time of surgery. Actuarial survival curves were compared using the Breslow test. Statistical significance was defined as a probability value of less than 0.05 for x2 and t tests and a probability value of less than 0.1 for the Cox proportional hazards model and the Breslow test.
Results
All patients had advanced heart failure of New York Heart Association functional class III or IV. Mean patient age was 49±12 years, and 309 patients (79%) were male. Etiology of heart failure was coronary artery disease in 177 patients (45%) and nonischemic cardiomyopathy in 213 patients (55%) (idiopathic in 191 patients and valvular in 22 patients). Mean Table 1 . Etiology of heart failure was similar in the two groups. Antiarrhythmic drugs, including amiodarone, were used more frequently in atrial fibrillation patients. Warfarin therapy at hospital discharge was more common in the atrial fibrillation patients; interestingly, there was a similar prevalence of previous clinical, arterial embolic events between the groups. Mean left ventricular ejection fraction was low in both groups but slightly higher in atrial fibrillation patients than in sinus rhythm patients. Echocardiographic left ventricular dimensions were similar in both groups, but atrial fibrillation patients had larger left atria.
Hemodynamic measurements before (initial) and after (final) in-hospital optimization of medical therapy are compared in Table 2 Values are given as mean+± 1 SD. in Figure 1 . At 1 year, actuarial survival was 52% for atrial fibrillation patients and 71% for sinus rhythm patients (p=0.001). Table 3 shows results of univariate and multivariate Cox proportional hazards model analyses for total mortality. In the univariate analysis with the proportional hazards model, final pulmonary capillary wedge pressure, final pulmonary artery systolic pressure, left ventricular ejection fraction, atrial fibrillation, final serum sodium, and presence of coro- Table 3 significantly improved the predictive accuracy of the model for total mortality (p<0.05). Figure 3 shows the total mortality relative risk associated with atrial fibrillation over a range of pulmonary capillary wedge pressures calculated from the proportional hazards model. The relative risk is greatest at the low pulmo- Figure 6 , in the low pulmonary capillary wedge pressure patients, sudden death-free survival was worse in atrial fibrillation patients than in patients who had never had atrial fibrillation (60% versus 92%, p=0.0001) and was again similar to that of high pulmonary capillary wedge pressure patients, regardless of rhythm (72%, p=0.12). In the high pulmonary capillary wedge pressure patients, atrial fibrillation did not confer additional sudden death risk (76% versus 73%, p=0.25). In the proportional hazards model, the interaction between atrial fibrillation and pulmonary capillary wedge pressure for sudden death did not reach statistical significance (p=0.14), perhaps because of the small number of events. Figure 7 shows 1-year actuarial sudden death-free survival for patients with (71% versus 59%, p=0.10) or chronic atrial fibrillation (49%, p=0.008). Survival was not statistically different between paroxysmal and chronic atrial fibrillation patients (p=0.54).
As shown in Figure 9 , actuarial 1-year sudden death-free survival in patients with sinus rhythm (83%) was significantly better than in paroxysmal atrial fibrillation patients (64%, p=0.004) or chronic atrial fibrillation patients (71%, p=0.004). Sudden death-free survival in paroxysmal atrial fibrillation patients was not statistically different from that in patients with chronic atrial fibrillation (p=0.69). patients (mean ejection fraction, 0.30); paradoxically, they found that atrial fibrillation was a good prognostic sign. These studies differ from the present study in that they examined patients with less severe heart failure, excluded patients with coronary artery disease, and contained smaller numbers of patients. In a small population of advanced heart failure patients (median left ventricular ejection fraction, 0.16; median pulmonary capillary wedge pressure, 25 mm Hg), Keogh et a14 reported that atrial fibrillation was not a risk factor for decreased survival; however, paroxysmal atrial fibrillation patients were not included. Our study suggests a potential explanation for these discrepancies. In patients with the most advanced ventricular dysfunction as indicated by elevated pulmonary capillary wedge pressure on therapy, atrial fibrillation was not associated with further impairment of survival, but in those with lower pulmonary capillary wedge pressure on therapy, suggestive of better ventricular function, atrial fibrillation conferred a greater risk of sudden death.
Relation ofAtrial Rhythm to Survival
Despite similar heart failure etiologies, pulmonary capillary wedge pressures, and left ventricular ejection fractions, patients with paroxysmal or chronic atrial fibrillation had significantly lower actuarial survival and sudden death-free survival than patients with sinus rhythm. There are several possible explanations for the adverse prognostic significance of atrial fibrillation in advanced heart failure. Atrial fibrillation, like reduced left ventricular ejection fraction or elevated pulmonary capillary wedge pressure, may be another marker of severity of left ventricular dysfunction. Atrial fibrillation may signify a degree of myocardial damage and fibrosis beyond that indicated by traditional measures of left ventricular dysfunction. In our population, patients achieving a pulmonary capillary wedge pressure of less than 16 mm Hg with vasodilators and diuretics have consistently enjoyed better overall and sudden death-free survivals than patients in whom low pressures could not be achieved. 12 The finding of decreased survival with atrial fibrillation compared with sinus rhythm in patients who achieved low pulmonary capillary wedge pressures but not in those whose pressures could not be lowered to that degree may be revealing. Perhaps any additional left ventricular impairment indicated by the presence of atrial fibrillation is relatively insignificant in the patients with the most severely depressed ventricular function. But in patients with low pulmonary capillary wedge pressure, who have relatively more favorable prognosis, the additional functional impairment may be important.
Another possible explanation for the decreased survival in atrial fibrillation is that it may increase the incidence of fatal thromboembolic events. Our study design does not allow us to assess the embolic risk of atrial fibrillation. We did not have autopsy data in most patients who died. We did not detect a higher incidence of clinically diagnosed embolic events in patients with atrial fibrillation. However, anticoagulation was used more frequently in atrial fibrillation than in sinus rhythm patients. The assessment of the
embolic risk from atrial fibrillation may be further confounded by emboli from clots originating within the dilated ventricles.
Theoretically, atrial fibrillation may contribute to the risk of ventricular tachyarrhythmias in advanced heart failure by inducing dispersion of refractoriness within the ventricle through long-short sequences of ventricular depolarization. 21, 22 In electrophysiological studies of patients with sustained ventricular tachycardia, longshort stimulation sequences can be effective for inducing sustained ventricular arrhythmias. 21 Interestingly, sudden death risk was not lower in paroxysmal atrial fibrillation patients than in chronic atrial fibrillation patients. Perhaps the presence of atrial fibrillation in advanced heart failure is indicative of underlying sinus node disease. If atrial fibrillation is paroxysmal, these patients may be predisposed to severe and potentially fatal bradyarrhythmias associated with spontaneous conversion to sinus rhythm.23 Embolism risk may be highest soon after onset of atrial fibrillation or reversion to sinus rhythm24-29; perhaps conversion in and out of atrial fibrillation increased sudden death risk from embolism in paroxysmal atrial fibrillation patients. Limitations
Our patient population consists of advanced heart failure patients, many of whom were undergoing evaluation for heart transplantation. These patients form one end of the spectrum of stable outpatients with heart failure, and the results of our study should not be generalized to patients with less severe heart failure. Twenty-seven percent of patients received heart transplantation and were censored from actuarial survival analysis at that point. However, similar percentages of patients with and without atrial fibrillation underwent heart transplantation (21% versus 28%,p=NS), and mean time to heart transplantation tended to be longer than mean time to death (107+ 79 versus 96+83 days, p=NS). The Measures of severity of left ventricular function and functional capacity have guided clinical decision making in assessing prognoses in advanced heart failure patients and considering the timing of heart transplantation. In general, patients with low capillary wedge pressure on vasodilator therapy enjoy longer survival and sudden death-free survival than those with high filling pressures. Atrial fibrillation identifies a subgroup among these patients with low filling pressures who have worse survival, one of which is similar to the very poor prognosis in sinus rhythm patients with high pulmonary capillary wedge pressure. Our data suggest that patients with paroxysmal or chronic atrial fibrillation may warrant earlier consideration for heart transplantation, an implication that awaits confirmation in a prospective study. Atrial fibrillation itself may directly contribute to sudden death or may be merely a marker of severity of left ventricular dysfunction. Prospective evaluation will be required to determine underlying mechanisms and whether systemic anticoagulation or aggressive attempts to restore and maintain sinus rhythm will improve survival.
